ScitoVation Nabs Leslie Recio, PhD DABT, as Chief Scientific Officer
Durham, North Carolina (PRWEB) April 28, 2022 -- ScitoVation is pleased to announce Leslie Recio, PhD, DABT, as the new Chief Scientific Officer. Dr. Recio
Stay updated with breaking news from Toxicological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Durham, North Carolina (PRWEB) April 28, 2022 -- ScitoVation is pleased to announce Leslie Recio, PhD, DABT, as the new Chief Scientific Officer. Dr. Recio
The research will focus on treating a recurrence of prostate cancer, for which there is just a 29% survival rate
Polluted air contributed to the deaths of more than 6.6 million people worldwide in 2019. It accounts for around 20 percent of newborn deaths globally, mostly due to preterm birth and low birth weight. Because of this, it is crucial that researchers
The University of Louisiana Monroe's El Sayed has been awarded funding towards research for a treatment for prostate cancer recurrence.
The National Cancer Institute approved a grant application by Dr. Khalid El Sayed, a Professor of Medicinal and Natural Products Chemistry in the School of Basic Pharmaceutical and Toxicological Sciences in the College of Pharmacy. The two-year grant provides $182,419 for year one and $164,794 for year two.